Kanishka Das Profile - Zacks Equity Research Blogger
4 Followers
Kanishka Das Zacks Equity Research
Financial Blogger
Success Rate
13 out of 26 ratings made a profit
Average Return
-1.10%
Average return per rating
Time Frame
Compare to
Copying Kanishka Das's trades since 2020 and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.1% per rating.
Stock Rating Distribution
82.14% Bullish
10.71% Bearish
7.14% Neutral
Distribution of Kanishka Das's ratings
Additional Information
Main Sector:General
Geo Coverage:
Best Rating
The most profitable rating made by Kanishka Das
Kanishka Das's Stock Coverage
Li Auto
Nov 05, 2020
Bullish
1Ratings
+10.30%
Insmed
Dec 24, 2025
Bullish
1Ratings
-37.30%
Nektar Therapeutics
Dec 24, 2025
Bullish
1Ratings
-0.80%
Lyell Immunopharma
Dec 24, 2025
Bullish
1Ratings
-76.00%
Mineralys Therapeutics, Inc.
Dec 24, 2025
Bullish
1Ratings
-36.80%
Immunocore Holdings
Jul 27, 2026
Neutral
1Ratings
―
0.00%
Viatris
Aug 12, 2026
Bullish
1Ratings
+10.10%
Neurocrine
Aug 12, 2026
Bullish
1Ratings
-8.50%
Amneal Pharmaceuticals
Aug 12, 2026
Bullish
1Ratings
+14.90%
Alvotech
Aug 12, 2026
Bullish
1Ratings
+35.90%
List of latest recommendations made by Kanishka Das. Click to expand and see Kanishka Das's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.